Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.760
-0.010 (-0.56%)
Apr 15, 2025, 4:00 PM EDT - Market closed
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$1,625
Profits / Employee
-$800,404
Market Cap
64.53M
Employees Chart
INO News
- 6 days ago - INOVIO to Present at Upcoming Scientific Conferences - PRNewsWire
- 4 weeks ago - Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - PRNewsWire
- 4 weeks ago - INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19 - PRNewsWire
- 4 weeks ago - INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025 - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals Inc (INO) Oppenheimer 35th Annual Healthcare Life Sciences Conference (Transcript) - Seeking Alpha
- 2 months ago - Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications - PRNewsWire
- 2 months ago - Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference - PRNewsWire